November 3, 2021
2 mins read

Guyana recognises Covaxin

Hailing the decision, the Indian High Commission in Guyana said that it is an important step forward in the post Covid partnership between both the countries….reports Asian Lite News

Guyana on Tuesday recognised Bharat Biotech’s Covaxin, India’s first indigenous vaccine against Covid-19.

Hailing the decision, the Indian High Commission in Guyana said that it is an important step forward in the post Covid partnership between both the countries.

On Monday, Australia also recognised Covaxin for allowing entry of travellers who had received the vaccine and five other countries also recognised the Indian vaccine certificate.

In a tweet, the High Commission of India in Guyana said, “Guyana has recognised India’s indigenous vaccine Covaxin -important step forward in the post-COVID partnership between India and Guyana.

“Now, all passengers aged 18 years and above travelling to Guyana must be vaccinated against Covid-19 before arrival. Passengers are required to present their vaccination card bearing their name of vaccine, date vaccine was inoculated and batch from an accredited facility.”

On Monday, the Ministry of External Affairs (MEA) said that five more countries — Estonia, Kyrgyzstan, State of Palestine, Mauritius and Mongolia — have recognised India’s vaccination certificate.

In a tweet in the evening, MEA spokesperson Arindam Bagchi said, “Mutual recognition of COVID-19 vaccination certificates continues! Five more recognitions for India’s vaccination certificate, including from Estonia, Kyrgyzstan, State of Palestine, Mauritius and Mongolia.”

“Australia had recognised Bharat Biotech’s Covaxin for allowing entry of travellers who had received the vaccine. The Therapeutic Goods Administration (TGA), the Australian drug regulator, announced that it has recognised two more Covid-19 vaccines not registered in Australia but used widely internationally, which includes Bharat Biotech’s Covaxin and BBIBP-CorV (manufactured by Sinopharm, China).

The TGA stated that with the recognition of Covaxin, and BBIBP-CorV, along with the previously announced recognition of Coronavac (manufactured by Sinovac, China) and Covishield (manufactured by AstraZeneca, India), many citizens of India and China as well as other countries in the region where these vaccines have been widely deployed will now be considered fully vaccinated on entry to Australia.

The TGA stated that it will facilitate the return of international students, and travel of skilled and unskilled workers to Australia.

ALSO READ: Delhi’s air quality may deteriorate post Diwali

Previous Story

Covid vaccination coverage crosses 106.85 cr

Next Story

Cong sweeps Himachal, Rajasthan; Trinamool in Bengal, NDA in N-E

Previous Story

Covid vaccination coverage crosses 106.85 cr

Next Story

Cong sweeps Himachal, Rajasthan; Trinamool in Bengal, NDA in N-E

Latest from -Top News

COP31 Taskforce Targets Ocean Climate Funding Gap

France and Brazil have launched a 25-country initiative at COP31 to accelerate ocean-based climate solutions, as new data highlights major funding gaps threatening the implementation of national commitments…reports Asian Lite News Desk

EU Faces Calls to Act on Bangladesh Rights Violations

Bangladesh’s political transition has done little to silence concerns over the country’s human rights record…writes Dr Sakariya Kareem More than two years after the student-led uprising that ended Sheikh Hasina’s rule in
Go toTop

Don't Miss

India’s Public Cloud market rebounds

SaaS continued to be the largest component of the overall

Apple’s Dominance Grows in India

Apple’s Q4 2023 performance in India paints a picture of